TY  - RPRT
TI  - Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including XBB.1.5 and BQ.1.1
AU  - Entzminger, K. C.
AU  - Fleming, J. K.
AU  - Entzminger, P. D.
AU  - Espinosa, L. Y.
AU  - Samadi, A.
AU  - Hiramoto, Y.
AU  - Okumura, C.
AU  - Maruyama, T.
PY  - 2023
DO  - 10.1101/2023.01.25.525589
UR  - https://www.biorxiv.org/content/10.1101/2023.01.25.525589v1
ID  - 10.1101/2023.01.25.525589
ER  -